Abstract: A method of recommending an object, an electronic device, and a storage medium are provided. The method includes: determining, in response to receiving target user behavior data of a target user from a target client, a target object according to the target user behavior data and at least one candidate user behavior data corresponding to a plurality of candidate users; and sending the target object to the target client, so as to recommend the target object to the target user, where each of the candidate user behavior data is stored in a predetermined block chain, each of the candidate user behavior data corresponds to at least one of a plurality of block chain nodes contained in a block chain network, and each of the candidate user behavior data indicates a preference of a candidate user for at least one candidate object.

Abstract: A method for compensating display of a spliced screen, including: obtaining a picture to be displayed; obtaining a theoretical brightness gain of at least one sub-display region in a plurality of sub-display regions; obtaining an actual brightness gain of the central region according to the theoretical brightness gain of at least part of the sub-display regions, and obtaining actual brightness gains of a plurality of first nodes in the non-central region according to the theoretical brightness gain of at least part of the sub-display regions; obtaining an actual brightness gain of at least part of the non-central region by using a bilinear interpolation method according to the actual brightness gains of the plurality of first nodes and an actual brightness gain of at least one second node on the central region; and compensating the picture to be displayed based on an actual brightness gain of the picture to be displayed.

Abstract: An impact-resistant balanced hydro-cylinder with pressure relief and buffering protection comprises a cylinder body (11), a piston (13), a piston rod (14), and a first valve core (21) and a second valve core (51) slidable relative to the cylinder body (11). A closed first gas cavity (22) and a closed second gas cavity (52) are respectively formed between the two valve cores and inner walls of two opposite ends of the cylinder body (11). A closed first oil cavity (32) and a closed second oil cavity (42) are respectively formed between the two valve cores and two end faces of the piston (13). A through hole (33) for the first oil cavity and a through hole (43) for the second oil cavity are respectively provided in the positions on the cylinder body (11) corresponding to the first oil cavity (32) and the second oil cavity (42).

Abstract: The preparation and use of systems to provide surrogate whole blood controls using coagulation modifiers to simulate human whole blood in coagulation assays are disclosed.

Abstract: Stabilized formulations containing a peptide, such as a glucagon, are described herein. The formulations are in the form of a solution or suspension, which exhibit little or no chemical degradation and/or aggregation of the peptide over an extended period of time. In some embodiments, the formulations are in the form of a solution containing the peptide, a solvent such as glycerin, and one or more thermal stabilizers. In other embodiments, the formulation is in the form of a suspension containing nano- and/or microparticles containing the peptide suspended in a non-aqueous, non-solvent. The nano- and/or microparticles can be prepared by micronizing the peptide with one or more humectants, such as salts, sugars, water-soluble polymers, and combinations thereof which increase the rate of dissolution of the peptide upon administration.

Abstract: Stabilized formulations containing a peptide, such as a glucagon, are described herein. The formulations are in the form of a solution or suspension, which exhibit ttle or no chemical degradation and/or aggregation of the peptide over an extended period of time. In some embodiments, the formulations are in the form of a solution containing the peptide, a solvent such as glycerin, and one or more thermal stabilizers. In other embodiments, the formulation is in the form of a suspension containing nano- and/or microparticles containing the peptide suspended in a non- aqueous, non-solvent. The nano- and/or microparticles can be prepared by micronizing the peptide with one or more humectants, such as salts, sugars, water-soluble polymers, and combinations thereof which increase the rate of dissolution of the peptide upon administration.